Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services... see more

OTCPK:MEDVF - Post Discussion

Medivolve Inc > Let us talk about QSC Revenue Now & increasing big in fall
View:
Post by Sarb99 on Aug 11, 2020 10:17am

Let us talk about QSC Revenue Now & increasing big in fall

Just say 2500 Antigen nasal swab 2500x$129= $322,500 per day and $9,675,000 per month

Just say 3000 Antibodies Rapid Blood Test 3000x$49= $147,000 per day and $4,410,000 per month

So, revenue starting in few weeks $9,675,000+$4,410,000=$14 Million per month
Can you imagine once they start popping up everywhere starting in September- October, Revenue can be in over $100 million in no time.
Then other investments:

  • Spectral Analytics Inc. (Covid-19 trial with two FDA approved drugs.)
  • Sunnybrook (researching for Vaccine)
  • Sinai Health Foundation (Researching for Mass testing)
  • 28% Interest in Colombian Full-Service Medical Clinic (https://business.facebook.com/ipssanaty/)
  • Exclusive Sales Rights for Emergency Use Authorized COVID-19 Lateral Flow Antibody Test Kit to other labs.
  • 30% interest in Glenco Medical Corp for sports injury (selling products and services)
  • 40% interest in Amino Therapeutics (Focused on developing biologic therapeutics for COVID-19)
Comment by MoneyGuy101 on Aug 11, 2020 11:05am
I'd imagine, since its vertically integrated, the margin of profit will be extremely high. Company will hit its market cap in EBITA in 2 months. Needless to say, the SP can't stay this low. Gonna move on those announcements. 
Comment by HoldMe on Aug 11, 2020 11:54am
Any idea who's antigen testing kit they will be selling? There's only 2 approved ones out there presently and I'm curious which it may be.  I would have assumed announcing a potential 154k kits a month in sales would have done something more with the stock price but not seeing it today. What's it going to take to get this stock moving and staying up? HM
Comment by marmalade on Aug 11, 2020 12:05pm
dividend could